Pal T - Search Results

1

The presence of germ line mosaicism in cleidocranial dysplasia.

Pal T, Napierala D, Becker TA, Loscalzo M, Baldridge D, Lee B, Sutphen R. Pal T, et al. Clin Genet. 2007 Jun;71(6):589-91. doi: 10.1111/j.1399-0004.2007.00812.x. Clin Genet. 2007. PMID: 17539909

2

Mismatch repair gene expression defects contribute to microsatellite instability in ovarian carcinoma.

Pal T, Sutphen R, Sellers T. Pal T, et al. Cancer. 2004 Jun 1;100(11):2485-6; author reply 2486. doi: 10.1002/cncr.20247. Cancer. 2004. PMID: 15160358 Free article. No abstract available.

3

BRCA1 and BRCA2 mutations in a study of African American breast cancer patients.

Pal T, Permuth-Wey J, Holtje T, Sutphen R. Pal T, et al. Cancer Epidemiol Biomarkers Prev. 2004 Nov;13(11 Pt 1):1794-9. Cancer Epidemiol Biomarkers Prev. 2004. PMID: 15533909

4

BRCA1 and BRCA2 mutations account for a large proportion of ovarian carcinoma cases.

Pal T, Permuth-Wey J, Betts JA, Krischer JP, Fiorica J, Arango H, LaPolla J, Hoffman M, Martino MA, Wakeley K, Wilbanks G, Nicosia S, Cantor A, Sutphen R. Pal T, et al. Cancer. 2005 Dec 15;104(12):2807-16. doi: 10.1002/cncr.21536. Cancer. 2005. PMID: 16284991 Free article.

5

Improved survival in BRCA2 carriers with ovarian cancer.

Pal T, Permuth-Wey J, Kapoor R, Cantor A, Sutphen R. Pal T, et al. Fam Cancer. 2007;6(1):113-9. doi: 10.1007/s10689-006-9112-x. Fam Cancer. 2007. PMID: 17160431 Free PMC article.

6

Sampling strategies for tissue microarrays to evaluate biomarkers in ovarian cancer.

Permuth-Wey J, Boulware D, Valkov N, Livingston S, Nicosia S, Lee JH, Sutphen R, Schildkraut J, Narod S, Parker A, Coppola D, Sellers T, Pal T. Permuth-Wey J, et al. Among authors: pal t. Cancer Epidemiol Biomarkers Prev. 2009 Jan;18(1):28-34. doi: 10.1158/1055-9965.EPI-08-0713. Cancer Epidemiol Biomarkers Prev. 2009. PMID: 19124477 Free PMC article.

7

Evaluation of phone-based genetic counselling in African American women using culturally tailored visual aids.

Pal T, Stowe C, Cole A, Lee JH, Zhao X, Vadaparampil S. Pal T, et al. Clin Genet. 2010 Aug;78(2):124-31. doi: 10.1111/j.1399-0004.2010.01466.x. Clin Genet. 2010. PMID: 20662853 Clinical Trial.

8

Modes of delivery of genetic testing services and the uptake of cancer risk management strategies in BRCA1 and BRCA2 carriers.

Pal T, Lee JH, Besharat A, Thompson Z, Monteiro AN, Phelan C, Lancaster JM, Metcalfe K, Sellers TA, Vadaparampil S, Narod SA. Pal T, et al. Clin Genet. 2014 Jan;85(1):49-53. doi: 10.1111/cge.12130. Epub 2013 Mar 21. Clin Genet. 2014. PMID: 23438721 Free PMC article.

9

Panel-based testing for inherited colorectal cancer: a descriptive study of clinical testing performed by a US laboratory.

Cragun D, Radford C, Dolinsky JS, Caldwell M, Chao E, Pal T. Cragun D, et al. Among authors: pal t. Clin Genet. 2014 Dec;86(6):510-20. doi: 10.1111/cge.12359. Epub 2014 Mar 20. Clin Genet. 2014. PMID: 24506336 Free PMC article.

10

Comparing universal Lynch syndrome tumor-screening programs to evaluate associations between implementation strategies and patient follow-through.

Cragun D, DeBate RD, Vadaparampil ST, Baldwin J, Hampel H, Pal T. Cragun D, et al. Among authors: pal t. Genet Med. 2014 Oct;16(10):773-82. doi: 10.1038/gim.2014.31. Epub 2014 Mar 20. Genet Med. 2014. PMID: 24651603 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

719 results

Search Page

Filters